Larimar Therapeutics Inc. LRMR
$3.42
▼ -3.61% 24H
About
Larimar Therapeutics Inc. is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases using its proprietary cell-penetrating peptide technology platform. This platform enables intracellular delivery of missing proteins to address devastating conditions with limited or no availab…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees71
TickerLRMR
Statistics
Market Cap$355.8M
Revenue (TTM)$0
Net Income-$165.7M
Net Margin—
EPS$-2.27
P/E-1.59
P/S—
P/B2.27
EV/EBITDA-0.94
ROE-109.8%
Dividend Yield—
Price$3.42
Data: Twelve Data · Revenue = mcap / P/S